# TELIX PHARMACEUTICAL LTD (TLX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TLX/

- Reporting holders: 3
- Reported value: $13.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $12.4K | 1,128 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $614 | 56 | 0.0% | 5 |
| [WoodTrust Financial Corp](https://holderbook.com/funds/1725247-woodtrust-financial-corp/) | $186 | 17,000 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $13.2K |
| Q2 2026 | 63 | $38.5M |
| Q1 2026 | 38 | $24.5M |
| Q4 2025 | 39 | $8.5M |
| Q3 2025 | 27 | $8.1M |
| Q2 2025 | 21 | $7.3M |
| Q1 2025 | 6 | $798.6K |
| Q4 2024 | 1 | $57.4K |